Characteristics of the Drip-and-Ship Paradigm for Patients with Acute Ischemic Stroke in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Man-Seok | - |
dc.contributor.author | Lee, Ji Sung | - |
dc.contributor.author | Park, Tai Hwan | - |
dc.contributor.author | Cho, Yong-Jin | - |
dc.contributor.author | Hong, Keun-Sik | - |
dc.contributor.author | Park, Jong-Moo | - |
dc.contributor.author | Kang, Kyusik | - |
dc.contributor.author | Lee, Kyung Bok | - |
dc.contributor.author | Kim, Jae Guk | - |
dc.contributor.author | Lee, Soo Joo | - |
dc.contributor.author | Lee, Jun | - |
dc.contributor.author | Choi, Kang-Ho | - |
dc.contributor.author | Kim, Joon-Tae | - |
dc.contributor.author | Cho, Ki-Hyun | - |
dc.contributor.author | Oh, Mi Sun | - |
dc.contributor.author | Yu, Kyung-Ho | - |
dc.contributor.author | Lee, Byung-Chul | - |
dc.contributor.author | Cha, Jae-Kwan | - |
dc.contributor.author | Kim, Dae-Hyun | - |
dc.contributor.author | Nah, Hyun-Wook | - |
dc.contributor.author | Lee, Juneyoung | - |
dc.contributor.author | Kim, Dong-Eog | - |
dc.contributor.author | Ryu, Wi-Sun | - |
dc.contributor.author | Kim, Beom Joon | - |
dc.contributor.author | Han, Moon-Ku | - |
dc.contributor.author | Bae, Hee-Joon | - |
dc.contributor.author | Song, Sook-Keun | - |
dc.contributor.author | Choi, Jay Chol | - |
dc.date.accessioned | 2021-09-03T17:26:54Z | - |
dc.date.available | 2021-09-03T17:26:54Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2016-11 | - |
dc.identifier.issn | 1052-3057 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/86968 | - |
dc.description.abstract | Background: Data on the drip-and-ship paradigm in Korea are limited. The present study aimed to evaluate the use of the drip-and-ship paradigm and the time delays and outcomes associated with the paradigm in Korea. Methods: We used data from the Clinical Research Center for Stroke-5 registry between January 2011 and March 2014. Among patients treated with tissue-type plasminogen activator (tPA), the use of the drip-and-ship paradigm was evaluated, and time delays and functional outcomes at 3 months were compared between patients treated with the paradigm and those treated directly at visits. Results: Among 1843 patients who met the eligibility criteria, 244 patients (13.2%) were treated with the drip-and-ship paradigm. Subsequent endovascular recanalization therapy was used in 509 patients (27.6%). The median time from symptom onset to groin puncture was greater in patients treated with the paradigm than in those treated directly at visits (305 versus 200 minutes, P < .001). In multivariate analysis, the risks of unfavorable functional outcomes and symptomatic intracranial hemorrhage were higher in ratio [OR] 2.15; 95% confidence interval [CI], 1.50-3.08; P < .001 and OR 1.78; 95% CI, 1.02-3.12; P = .041, respectively). Conclusions: In Korea, the drip-and-ship paradigm was used in less than 15% of all patients treated with tPA. The use of the paradigm might cause an increase in the onset-to-groin puncture time. Additionally, clinical outcomes might be worse in patients treated with the paradigm than in those treated directly at visits. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.subject | TISSUE-PLASMINOGEN ACTIVATOR | - |
dc.subject | INTRAVENOUS THROMBOLYSIS | - |
dc.subject | INTRAARTERIAL TREATMENT | - |
dc.subject | HELICOPTER TRANSPORT | - |
dc.subject | TEMPORAL TRENDS | - |
dc.subject | OUTCOMES | - |
dc.subject | REGISTRY | - |
dc.subject | THERAPY | - |
dc.subject | TRIAL | - |
dc.subject | THROMBECTOMY | - |
dc.title | Characteristics of the Drip-and-Ship Paradigm for Patients with Acute Ischemic Stroke in South Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Juneyoung | - |
dc.identifier.doi | 10.1016/j.jstrokecerebrovasdis.2016.07.015 | - |
dc.identifier.scopusid | 2-s2.0-84994691909 | - |
dc.identifier.wosid | 000389520800022 | - |
dc.identifier.bibliographicCitation | JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, v.25, no.11, pp.2678 - 2687 | - |
dc.relation.isPartOf | JOURNAL OF STROKE & CEREBROVASCULAR DISEASES | - |
dc.citation.title | JOURNAL OF STROKE & CEREBROVASCULAR DISEASES | - |
dc.citation.volume | 25 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 2678 | - |
dc.citation.endPage | 2687 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | TISSUE-PLASMINOGEN ACTIVATOR | - |
dc.subject.keywordPlus | INTRAVENOUS THROMBOLYSIS | - |
dc.subject.keywordPlus | INTRAARTERIAL TREATMENT | - |
dc.subject.keywordPlus | HELICOPTER TRANSPORT | - |
dc.subject.keywordPlus | TEMPORAL TRENDS | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | REGISTRY | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordPlus | THROMBECTOMY | - |
dc.subject.keywordAuthor | Acute ischemic stroke | - |
dc.subject.keywordAuthor | endovascular treatment | - |
dc.subject.keywordAuthor | drip-and-ship | - |
dc.subject.keywordAuthor | outcome assessment | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.